Envisagenics
New York, New York, United States
Envisagenics is an Artificial Intelligence-driven, biotechnology company that focuses on the discovery of novel RNA splicing events that cause cancer and other genetic diseases. The company’s principal technology is the SpliceCore® discovery platform, which re-envisions the human genome with a validated exon-centric approach, combined with machine learning algorithms and high-performance computing. It is up to 250 times more likely to discover novel targets than gene-centric discovery tools. Using innovative technology and RNA analysis expertise, Envisagenics accelerates the development of highly specific therapeutics that modulate RNA splicing events that drive pathogenesis of oncology, neurodegenerative, and metabolic disorders.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2014
- Website
- www.envisagenics.com/
Categories
Only accessible to MedStartr community members.
Join nowWhat do you think of Envisagenics?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now